Skip to main content
. 2020 Nov 19;9(1):1844403. doi: 10.1080/2162402X.2020.1844403

Table 3.

Studies comparing different PD-L1 IHC assays

 
# and types of tested tumors
SP142
SP263
28–8
22C3
E1L3N
Ref
Hirsch et al. 39 NSCLC - + + + NE 26
Karim et al. 29 NSCLC + NE + +   27
Scognamiglio et Chen 96 HNSCC + +++ NE NE + 21
Rimm et al. 90 NSCLC - NE + + NE 28

Abbreviations: #, number; HNSCC, head and neck squamous cell carcinoma; NE, not evaluated; NSCLC, non–small-cell lung cancer.

SP142 (Spring Bioscience), SP263 (Ventana), 28–8 (Dako), 22C3 (Dako) and E1L3N (Cell Signaling)